Printer Friendly

FRANCIS L. DALE ELECTED DIRECTOR OF ICN BIOMEDICALS INC.

 FRANCIS L. DALE ELECTED DIRECTOR OF ICN BIOMEDICALS INC.
 COSTA MESA, Calif., April 27 /PRNewswire/ -- ICN Biomedicals Inc.


(AMEX: BIM) announced today that Francis L. Dale was elected to the board of directors of the biotechnology research products and medical diagnostics company.
 Dale is a senior associate of Moxham Carver Inc., an affiliate of Ketchum Inc.
 In addition, the board of directors elected Milan Panic to the additional position of president of the company. Panic is chairman and chief executive officer of ICN Biomedicals and chairman, president and chief executive officer of its parent company, ICN Pharmaceuticals Inc.
 John E. Giordani was elected senior vice president of ICN Biomedicals and chief financial officer. Giordani retains his position as senior vice president and chief financial officer of the parent company, ICN Pharmaceuticals.
 Dale, who had been a member of the board of Viratek Inc., another ICN Pharmaceutical subsidiary, is a former president and publisher of the Los Angeles Herald Examiner and vice president of the Hearst Corp. He served as United States Ambassador to the United Nations and other international organizations in Geneva, and as special assistant to the assistant secretary of state from 1974 to 1977. Prior to 1974, he served as president and publisher of the Cincinnati Enquirer and practiced law with the firm of Frost & Jacobs, Cincinnati.
 ICN Biomedicals Inc. is a major world supplier to biotechnology research products and medical diagnostics.
 -0- 4/27/92
 /CONTACT: Jack Sholl of ICN Biomedicals, 714-545-0100, ext. 3013/
 (BIM) CO: ICN Biomedicals Inc. ST: California IN: MTC SU: PER


AL-CH -- LA020 -- 3230 04/27/92 13:40 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 27, 1992
Words:267
Previous Article:NET INCOME UP 38 PERCENT FOR FIRST QUARTER 1992
Next Article:ACME UNITED DECLARES REGULAR QUARTERLY DIVIDEND OF 5 CENTS


Related Articles
ICN BIOMEDICALS INC. DECLARES QUARTERLY DIVIDEND
ICN BIOMEDICALS INC. INCREASES QUARTERLY DIVIDEND 13 PERCENT
ICN BIOMEDICALS ANNOUNCES SECOND QUARTER DIVIDEND
ICN AND SUBSIDIARY COMPANIES ANNOUNCE MANAGEMENT APPOINTMENTS
ICN BIOMEDICALS INC. ANNOUNCES FOURTH QUARTER DIVIDEND
ICN BIOMEDICALS INC. ANNOUNCES FIRST QUARTER DIVIDEND
MACDONALD NAMED PRESIDENT OF ICN BIOMEDICALS
ICN BIOMEDICALS ANNOUNCES YEAR-END RESULTS
ICN BIOMEDICALS INC. ANNOUNCES SECOND QUARTER DIVIDEND
ICN BIOMEDICALS ISSUES $62 MILLION IN PREFERRED STOCK

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters